Planned Parenthood of the Pacific Southwest
Planned Parenthood of the Pacific Southwest was paid $33.43M by Medicaid between Jan 2018 and Nov 2024, across 59 billing codes. Its largest line is S0199, Medically induced abortion by oral ingestion of medication including all associated services and supplies (e.g., patient counseling, office visits, confirmation of pregnancy by hcg, ultrasound to confirm duration of pregnancy, ultrasound to confirm completion of abortion) except drugs — 11% of everything it billed.
COACHELLA, CA 92236
Next to other Community Health Clinic/Center providers in California
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 20,994 | $1.21M | |
| 2019 | 79,658 | $5.33M | |
| 2020 | 77,110 | $5.51M | |
| 2021 | 82,475 | $4.39M | |
| 2022 | 105,755 | $5.36M | |
| 2023 | 116,133 | $5.87M | |
| 2024incomplete | 117,854 | $5.77M |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| S0199 | Medically induced abortion by oral ingestion of medication including all associated services and supplies (e.g., patient counseling, office visits, confirmation of pregnancy by hcg, ultrasound to confirm duration of pregnancy, ultrasound to confirm completion of abortion) except drugs | 11% | 6,757 | 6,743 | $3.58M |
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | 9.8% | 3,420 | 3,403 | $3.26M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 8.8% | 46,977 | 45,657 | $2.94M |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 7.7% | 54,911 | 54,093 | $2.58M |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 7.7% | 54,901 | 54,093 | $2.57M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 7.3% | 25,020 | 24,346 | $2.46M |
| S4993 | Contraceptive pills for birth control | 5.3% | 15,076 | 14,929 | $1.76M |
| J3490 | Unclassified drugs | 4.8% | 37,628 | 35,526 | $1.60M |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 4.6% | 9,733 | 9,656 | $1.53M |
| 87806 | 3.9% | 50,442 | 48,084 | $1.30M | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 3.9% | 28,373 | 27,664 | $1.29M |
| 59840 | 2.8% | 3,056 | 3,048 | $943K |
47 more codes
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 2.6% | 27,792 | $871K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 2.6% | 9,940 | $858K |
| J7298 | Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg | 2.0% | 683 | $653K |
| S0190 | Mifepristone, oral, 200 mg | 1.7% | 9,387 | $582K |
| J7304 | Contraceptive supply, hormone containing patch, each | 1.7% | 712 | $554K |
| J7300 | Intrauterine copper contraceptive (paragard) | 1.4% | 566 | $480K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 1.3% | 10,228 | $438K |
| J7303 | Contraceptive supply, hormone containing vaginal ring, each | 1.3% | 450 | $428K |
| 11981 | 1.0% | 1,666 | $336K | |
| A4267 | Contraceptive supply, condom, male, each | <1% | 24,104 | $292K |
| 58300 | <1% | 1,630 | $235K | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 2,478 | $205K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 5,586 | $183K |
| J7301 | Levonorgestrel-releasing intrauterine contraceptive system (skyla), 13.5 mg | <1% | 209 | $166K |
| 81025 | <1% | 52,533 | $149K | |
| 99000 | <1% | 40,011 | $147K | |
| J7296 | Levonorgestrel-releasing intrauterine contraceptive system, (kyleena), 19.5 mg | <1% | 147 | $137K |
| 99152 | <1% | 2,856 | $134K | |
| 11982 | <1% | 929 | $102K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 454 | $83K |
| 99201 | <1% | 1,802 | $80K | |
| 87529 | <1% | 999 | $59K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 3,041 | $57K |
| 83986 | <1% | 17,794 | $56K | |
| 59841 | <1% | 111 | $53K | |
| Q3014 | Telehealth originating site facility fee | <1% | 2,227 | $52K |
| 58301 | <1% | 933 | $40K | |
| 87210 | <1% | 10,859 | $38K | |
| S0191 | Misoprostol, oral, 200 mcg | <1% | 8,451 | $26K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 127 | $13K |
| 85018 | <1% | 10,778 | $12K | |
| 90651 | <1% | 41 | $11K | |
| 57454 | <1% | 155 | $10K | |
| 86701 | <1% | 1,403 | $10K | |
| S5000 | Prescription drug, generic | <1% | 1,876 | $10K |
| 90385 | <1% | 200 | $10K | |
| S5199 | Personal care item, nos, each | <1% | 2,120 | $10K |
| 81002 | <1% | 3,953 | $9K | |
| S9445 | Patient education, not otherwise classified, non-physician provider, individual, per session | <1% | 573 | $7K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 116 | $7K |
| 11976 | <1% | 57 | $6K | |
| 86901 | <1% | 2,027 | $2K | |
| 76998 | <1% | 26 | $2K | |
| Q0144 | Azithromycin dihydrate, oral, capsules/powder, 1 gram | <1% | 276 | $2K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 655 | $729.37 |
| A4268 | Contraceptive supply, condom, female, each | <1% | 16 | $39.52 |
| 36415 | Collection of venous blood by venipuncture | 0% | 708 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.